|
Video: What is a Stock Split?
|
|
Artelo Biosciences is a clinical stage biopharmaceutical company focused on developing and commercializing treatments intended to modulate endogenous signalling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network throughout the body. Co. is developing a G protein-coupled receptor targeting synthetic small molecule program, ART27.13, as a treatment for anorexia associated with cancer; ART26.12, which a small molecule inhibitor of Fatty Acid Binding Protein 5, for cancer therapeutic and anxiety-related disorder, including post-traumatic stress disorder; and ART12.11, a solid-state composition of cannabidiol. According to our ARTL split history records, Artelo Biosciences has had 2 splits. | |
|
Artelo Biosciences (ARTL) has 2 splits in our ARTL split history database. The first split for ARTL took place on May 11, 1994. This was a 1 for 10
reverse split, meaning for each 10
shares of ARTL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. ARTL's second split took place on August 10, 2022. This was a 1 for 15 reverse split, meaning for each 15 shares of ARTL owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 6.66666666666667 share position following the split.
When a company such as Artelo Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ARTL split history from start to finish, an original position size of 1000 shares would have turned into 6.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Artelo Biosciences shares, starting with a $10,000 purchase of ARTL, presented on a split-history-adjusted basis factoring in the complete ARTL split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/24/2019 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$73.95 |
|
End price/share: |
$1.28 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.27% |
|
Average Annual Total Return: |
-56.88% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$173.16 |
|
Years: |
4.82 |
|
|
|
Date |
Ratio |
05/11/1994 | 1 for 10
| 08/10/2022 | 1 for 15 |
|
|